版本:
中国

BRIEF-Alexion Pharmaceuticals says long-term data confirm benefits of Strensiq

May 15 Alexion Pharmaceuticals Inc

* Alexion Pharmaceuticals - long-term data confirm benefits of treatment with strensiq in adolescents and adults with hypophosphatasia through 5 years Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐